The Utility of feNO in the Differential Diagnosis of Chronic Cough

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

February 10, 2017

Study Completion Date

March 9, 2017

Conditions
Cough
Interventions
DRUG

Montelukast (High FeNO group)

Montelukast 10 mg film-coated tablet contains montelukast sodium equivalent to 10 mg montelukast patients to take (oral use) one tablet per day for 28 days

DRUG

Prednisolon, Montelukast (High FeNO)

Prednisolone 5 mg, patients to take 4 tablets per day for 14 days then take Montelukast 10 mg tablet per day for another 14 days.

DRUG

Montelukast (Low FeNO group)

Montelukast 10 mg film-coated tablet contains montelukast sodium equivalent to 10 mg montelukast patients to take one tablet per day for 28 days

Trial Locations (1)

HU16 5JQ

Respiratory Medicine, Clinical trials Unit, Castle Hill Hospital, Cottingham

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aerocrine AB

INDUSTRY

lead

Hull University Teaching Hospitals NHS Trust

OTHER_GOV